Abivax (ABVX) Gains from Investment Securities (2024 - 2025)
Abivax (ABVX) posted quarterly Gains from Investment Securities of $74.0 million for Q3 2025, up 25602.0% year-over-year from N/an in Q3 2024, and up 3350.35% quarter-over-quarter from -$2.3 million in Q2 2025.
Abivax (ABVX) Gains from Investment Securities (2024 - 2025) Analysis & Trends
Abivax's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $74.0 million for Q3 2025.
- In Q3 2025, Gains from Investment Securities rose 25602.0% year-over-year to $74.0 million; the TTM figure through Mar 2026 stood at $71.7 million (up 2224.68% YoY), while the FY2025 annual figure was $72.6 million, up 4695.01% from the prior year.
- Gains from Investment Securities for Q3 2025 stood at $74.0 million, up from -$2.3 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $74.0 million in Q3 2025, with the low at -$2.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 73.95 Mn |
| Sep 30, 2025 | 73.95 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -2.28 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | -293,863.74 |
| Dec 31, 2024 | -293,863.74 |
| Sep 30, 2024 | 287,733.51 |
| Sep 30, 2024 | 287,733.51 |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | -417,162.92 |
| Mar 31, 2024 | -417,162.92 |